CHMP provides positive opinion for EU label update for Novo Nordisk's Tresiba® based on data from SWITCH trials
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via GlobeNewswire
Upcoming Life Sciences Events
- April 2024
- London: BioTrinity 2024
- Singapore: Asia Bio Partnering Forum
- London: LSX World Congress
Latest company news
There are currently no news available for this portal